New Tool Helps Physicians Tailor Hormone Therapy For High-risk Prostate Cancer Patients

Using one of the largest databases of prostate cancer outcomes in the United States, Fox Chase Cancer Center researchers have developed a prediction tool that uses a patient's clinical information to estimate the benefit of adding androgen deprivation therapy of various durations to radiation therapy.

Read the whole article on Science Daily

More from Science Daily